ATA Therapy

Harnessing genetic technology for personalized cancer treatment

ATA Vaccine Preparation Therapy utilizes autologous cell vaccines derived from a patient’s circulating tumor cells (CTCs) to stimulate the immune system’s response against cancer cells. By harnessing the body’s natural defenses, this innovative therapy offers a personalized approach to cancer treatment.

ATA Therapy
Sample type
Whole peripheral blood sample
Sample Size
25 ml of whole peripheral blood
Cancer type
Cancer patients with either solid tumors, or invasive cancers.
Turnaround time
30 days

How it works?

The vaccine is prepared using antigens extracted from the patient’s Circulating Tumor Cells (CTCs).

The antigens can stimulate the immune system to recognize and attack cancer cells effectively.

When it’s administered into the body, the vaccine triggers an immune response, targeting and eliminating cancer cells.

ATA therapy – looks for – Tumor cells fragments – helps in developing autologous cell vaccine from patient’s tumor cells.

How it helps?

ATA Vaccine Preparation Therapy holds promise as an immunotherapy option, with the goal of stopping tumor growth, preventing cancer recurrence, and enhancing overall survival rates.
This therapy offers rapid immune response activation, contributing to its effectiveness in combating cancer.

Why choose ATA Therapy?

Patients may consider ATA Therapy when conventional treatment options are not working for their specific cancer.

Whether the disease is stable, or the patient is at risk of recurrence, this therapy offers an advanced approach to cancer treatment.

The therapy has demonstrated proven efficacy in treating cancer with durable tumor regressions and progression-free survival.


Book an appointment

The first step towards personalized cancer care is scheduling an appointment with us.


30 minutes value packed consultation

Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.


Finding the right tests

We guide you through the process of selecting the most effective tests for your specific cancer.


Personalized results

We deliver precise results that guide treatment decisions and enhance outcomes.

Why clinicians prefer ATA Therapy than other similar tests?

Dr Meghan Watts

“RGCC’s ChemoSNiP test guides my treatment decisions with precision. It helps me tailor chemotherapy regimens to each patient’s genetic profile, improving efficacy and minimizing side effects. It’s an essential tool in personalized cancer care.”

Request a Second Opinion

Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.

Useful Information

Requires 20-30 ml of blood sample

Patients need to avoid chemotherapy, targeted therapies, radiation, IVs, and Ozone therapy 7 days before ATA VACCINE administration.

Patients should not be on immune suppression therapy up to 45 days prior to the application of ATA VACCINE.

Start your personalized cancer journey with us!

Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.

    Frequently Asked Questions

    • Can tests be conducted during ongoing treatment?

      Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.

    • What happens to my blood sample post-testing?

      Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells. Once testing is complete, your sample is stored for up to six months in case further analysis is needed.

    • Is a blood sample sufficient?

      Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.

    • Can the origin of a tumor be determined by the tests?

      Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.

    • What tests are effective in identifying the emergence of secondary tumors?

      RGCC tests like Metastat accurately detect the development of secondary tumors.

    • How do tests personalize cancer treatment?

      Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.

    • What are CTCs and CSCs?

      Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.

    • Do tests reveal drug resistance and sensitivity?

      Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.

    Genetic Precision for optimized cancer treatment

    Exhausted from trying various cancer treatments? Consider ATA therapy. It activates and stimulates the immune system to effectively targets cancer cells. Whether it’s active cancer or recurrence, ATA therapy offers promising results. Embrace a treatment that works best for your cancer!